These 2 Stocks Are “In Rarefied Air Among Investment Opportunities”

One expert says these 2 stocks could see double-digit upside over the next twelve months.

MoffettNathanson analyst Lisa Ellis said in a note from Tuesday that two credit card companies are “in rarefied air among investment opportunities.”

Ellis was referring to Mastercard (NYSE: MA) and Visa (NYSE: V), two of the market’s most reliable profit generators.

In the note, Ellis reiterated her Buy rating on both stocks, and raised her price target for Mastercard to $365 and for Visa to $230, suggesting upside of 18% and 19%, respectively.

The analyst doesn’t see any end in sight for both stocks’ stellar financial performances. Over the last year, both stocks have surged with Visa shares gaining 40% and Mastercard shares rising 58%.

According to Ellis, while Mastercard has outperformed Visa over the last year, both companies have been “permanently rerated,” and their valuations aren’t likely to fall because both companies have “demonstrated the consistency” in their business models.

They’ve also “dispelled disruption fears with [their] recent spate of partnership with digital wallets (e.g., Paytm, Alipay) and tech giants (e.g., Apple, Amazon),” Ellis wrote.

Ellis added that the key for Visa will be to close its share price performance with Mastercard, and could do so if it’s able to successfully integrate its European platform.

Susquehanna analyst James Friedman has said that Visa could close its valuation gap with Mastercard thanks to its “prominent commercial practice, targeting key international markets, and is experimenting with service fees.”

While Wedbush’s Moishe Katri said Visa’s earnings “will likely be augmented by ongoing efforts to target other, relatively under-penetrated alternative payments markets, including [business-to-business].”

 
Trending Ideas

Featured Stocks On The Move

Daily Rundown

Top 3 Stocks in Leading Sectors
  • 3 Software Stocks To Buy Now

    International Business Machines Corporation (IBM) International Business Machines Corporation (IBM) is a global leader in cloud computing, AI, and enterprise software. The company provides IT infrastructure, cybersecurity, and quantum computing... Read More

  • 3 Food Stocks To Buy Now

    The Campbell’s Company (CPB) The Campbell’s Company is a leading producer of packaged foods and beverages, known for its soups, sauces, and snacks. With brands like Campbell’s, Pepperidge Farm, and... Read More

  • 3 Utility Stocks To Buy Now

    IDACORP, Inc. (IDA) IDACORP, Inc. is a utility holding company that provides electricity through its subsidiary, Idaho Power. The company focuses on renewable energy initiatives, grid modernization, and sustainable power... Read More

  • 3 Biotechnology Stocks To Buy Now

    Xeris Biopharma Holdings, Inc. (XERS) Xeris Biopharma Holdings, Inc. is a specialty pharmaceutical company focused on developing and commercializing innovative injectable drug formulations. Its proprietary technology enhances drug stability and... Read More

  • 3 Consumer Service Stocks To Buy Now

    TripAdvisor, Inc. (TRIP) TripAdvisor, Inc. operates the world’s largest travel guidance platform, offering user-generated reviews, price comparisons, and booking services for hotels, attractions, and restaurants worldwide. Chart Wynn Resorts, Limited... Read More

  • 3 Software Stocks To Buy Now

    Udemy, Inc. (UDMY) Udemy, Inc. is an online learning platform offering a vast catalog of courses across various fields. The company connects learners with expert instructors, providing affordable and accessible... Read More

  • 3 Energy Stocks To Buy Now

    Ranger Energy Services, Inc. (RNGR) Ranger Energy Services, Inc. provides well services and support for oil and gas production. The company specializes in high-spec rig solutions, completion services, and workover... Read More

  • 3 Pharmaceutical Stocks To Buy Now

    ACADIA Pharmaceuticals Inc. (ACAD) ACADIA Pharmaceuticals Inc. is a biopharmaceutical company focused on developing therapies for central nervous system disorders. The company’s lead product, NUPLAZID, is used to treat Parkinson’s... Read More